How nicotine affects brain development in children exposed during pregnancy

Nicotinic modulation of excitatory synapse development in the prefrontal cortex

NIH-funded research University of Colorado Denver · NIH-11103125

This study is looking at how being exposed to nicotine during pregnancy affects brain development in babies, especially in areas that help with thinking and learning, which could help us find better ways to prevent and treat conditions like ADHD and autism.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project IDNIH-11103125 on NIH RePORTER

What this research studies

This research investigates the impact of prenatal nicotine exposure on the development of excitatory synapses in the prefrontal cortex, which is crucial for cognitive functions. By using advanced techniques like two-photon imaging and electrophysiology, the study aims to understand how nicotine interacts with specific receptors in the brain to influence synapse maturation. The findings could reveal important mechanisms behind neurodevelopmental disorders such as ADHD and autism, potentially leading to new therapeutic strategies. Patients may benefit from insights that could improve prevention and treatment approaches for these conditions.

Who could benefit from this research

Good fit: Ideal candidates for participation or benefit from this research include pregnant individuals who smoke or use e-cigarettes and their children who may be at risk for ADHD or autism spectrum disorders.

Not a fit: Patients who are not pregnant or those who do not have children at risk for neurodevelopmental disorders may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and management of neurodevelopmental disorders linked to prenatal nicotine exposure.

How similar studies have performed: Previous research has shown that understanding cholinergic signaling can lead to significant insights in neurodevelopment, suggesting this approach has potential for success.

Where this research is happening

Aurora, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Attention deficit hyperactivity disorder
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.